Physician profile
Genny Wright
NPI 1306412119
$7,994.25
in general payments reported to CMS, 2019-2025
26 companies · $1,918 in 2025
The $1,918 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $137 · 2023: $2,653 · 2024: $3,286 · 2025: $1,918.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,677 · Travel and Lodging: $1,180 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,676.89 |
| Travel and Lodging | $1,179.69 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,358.91 | 2023-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $558.60 | 2024-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Astrazeneca Pharmaceuticals Lp | $453.66 | 2023-2025 | Farxiga, Lokelma, Brilinta |
| Abbott Laboratories | $314.84 | 2024 | Mitraclip |
| Heartflow, INC. | $256.29 | 2024-2025 | |
| Amgen INC. | $248.12 | 2023-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $211.92 | 2023-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $172.66 | 2023-2025 | |
| Cvrx, INC. | $152.52 | 2024-2025 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $152.25 | 2024-2025 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $150.21 | 2023-2024 | Inpefa |
| Inari Medical, INC. | $136.67 | 2022 | |
| Janssen Pharmaceuticals, INC | $134.84 | 2023-2024 | Xarelto |
| Novo Nordisk INC | $131.06 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $103.41 | 2023-2025 | Verquvo |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $98.75 | 2023-2024 | |
| Philips North America LLC | $90.25 | 2024 | (6342) Intrasight Integ |
| Kestra Medical Technology Services, INC. | $68.89 | 2023-2025 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $43.80 | 2023-2025 | |
| Alnylam Pharmaceuticals INC. | $33.95 | 2025 | Amvuttra |
| Pfizer INC. | $31.98 | 2025 | |
| Inspire Medical Systems, INC. | $21.68 | 2025 | Inspire |
| Grifols USA, LLC | $20.18 | 2024 | Thrombate III |
| Bridgebio Pharma, INC. | $17.49 | 2025 | Attruby |
| Kiniksa Pharmaceuticals International, Plc | $16.70 | 2024 | Arcalyst |
| Stryker Corporation | $14.62 | 2024 | Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Genny Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.